Warfarin combined with low dose aspirin in myocardial infarction did not provide clinical benefit beyond that of aspirin alone

Evidence-Based Medicine

Volumn 7, Issue 5, 2002, Pages 140-

  Fiore, Louis D ^a   Ezekowitz, M D ^b   Brophy, M T ^b  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; WARFARIN;

BLEEDING; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFICACY; DRUG USE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; LONG TERM CARE; MORTALITY; OUTCOMES RESEARCH; PATIENT SELECTION; RECURRENT DISEASE; RISK FACTOR; SHORT SURVEY; STROKE; UNITED STATES;

EID: 3042640762     PISSN: 13565524     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebm.7.5.140     Document Type: Short Survey

References (3)

1. Anand SS, Yusuf S, Poque J, et al. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results. Circulation 1998;98:1064-70,
2. Moshfegh K, Redondo M Julmy F, et al. Antiplatelet effects of clopidogrel compared wit aspirin after myocardial infraction: enhaced inhibitory effects of combination therapy.J Am Coll Cardiol 2000;36.699-705.
3. Yusuf S, Zhao F, Mehta SR, et aL Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.